1. Research on impurity of pentoxifylline and glucose injection
Chinese Pharmaceutical Journal 2014;49(9):773-775
OBJECTIVE: To study the impurity of pentoxifylline and glucose injection and confirm its structure and source. METHODS: LC-MS was used to speculate the structure of the impurity. The impurity was synthesized by using theobromine and 1, 3-di-bromopropane as the starting materials and the structure was identified by IR, LC-MS, 1H-NMR, and 13C-NMR. RESULTS: The impurity was identified to be 1, 1′-(propane-1, 3-diyl)bis(3, 7-dimethyl-3, 7-dihydro-1H-purine-2, 6-dione). CONCLUSION: The study provides theoretical basis for the control of impurity in the production process and quality assessment of pentoxifylline and glucose injection.
2.A surveillance on risk factors related to chronic noncommunicable diseases among adults in Guangzhou in 2005.
Wei-jia LIU ; Bo-heng LIANG ; Lin DU
Chinese Journal of Epidemiology 2008;29(1):101-102
Adolescent
;
Adult
;
Aged
;
China
;
epidemiology
;
Chronic Disease
;
epidemiology
;
Female
;
Humans
;
Male
;
Middle Aged
;
Population Surveillance
;
Risk Factors
;
Young Adult
3.Prediction of the possible tertiary structure alterations of p53 protein following point mutation in p53 gene condon 282 in lung cancer cells.
Chang-hu DU ; Jun XU ; Nan-shan ZHONG
Journal of Southern Medical University 2006;26(10):1458-1459
This study was carried out to predict the possible tertiary structure alterations of p53 protein after point mutation of p53 gene condon 282 in lung cancer cells based on the latest 3D structure analysis platform series of Phyre software. It was found that the p53 gene condon 282 mutation (Arg/Leu) may destabilize the H2 helix and DNA binding in the major groove by compromising the contacts of p53 protein with the beta-hairpin of DNA binding surface.
Amino Acid Sequence
;
Base Sequence
;
Codon
;
genetics
;
Humans
;
Lung Neoplasms
;
genetics
;
pathology
;
Models, Molecular
;
Molecular Sequence Data
;
Point Mutation
;
Protein Structure, Tertiary
;
Tumor Suppressor Protein p53
;
chemistry
;
genetics
4.Correlation between serological screening of human T-lymphotropic virus antibodies and confirmatory tests
Yanqing DENG ; Hao WANG ; Zhengang SHAN ; Junmou XIE ; Rongsong DU ; Xunnan XIAO ; Zhongping LI ; Xia RONG ; Boquan HUANG
Chinese Journal of Blood Transfusion 2023;36(11):1022-1025
【Objective】 To explore the correlation between serological screening of human T-lymphotropic virus antibodies (anti HTLV) and Western blot(WB) confirmatory tests among blood donors, so as to explore the infection status of HTLV Ⅰ/Ⅱ in Guangzhou. 【Methods】 The anti HTLV Ⅰ/Ⅱ enzyme-linked immunosorbent assay(ELISA) kit was used to screen voluntary blood donors from Guangzhou Blood Center from July 2016 to August 2022. WB was used to confirm 395 reactive blood samples by ELISA. The correlation between the S/CO values of anti HTLV Ⅰ/Ⅱ ELISA reagents and the confirmatory test was analyzed using ROC curves. 【Results】 The results showed that 25 out of 395 initially screened reactive blood donor samples were confirmed as HTLV positive by WB, while 16 were uncertain. ROC curve analysis showed a correlation between the S/CO values by ELISA and the confirmatory test results: the S/CO value at the highest Youden index was 3.789, which was the optimal threshold. The S/CO value had a certain correlation with the predicted positive rate of confirmatory results (P<0.05): the larger the S/CO value, the higher the predicted positive value. The overall prevalence of HTLV in Guangzhou is relatively low. 【Conclusion】 The prevalence of HTLV among blood donors in Guangzhou is low.Since the false positive rate of HTLV Ⅰ/Ⅱ antibody by ELISA serological screening is high, the confirmatory testing is particularly important.
5.Prevalence of human T-lymphocyte leukemia virus among blood donors in Guangzhou
Yuxiao LI ; Xia RONG ; Bo HE ; Rongsong DU ; Zhengang SHAN ; Qiao LIAO
Chinese Journal of Blood Transfusion 2025;38(2):222-226
[Objective] To analyze the prevalence of human T-lymphocyte leukemia virus (HTLV) among blood donors in Guangzhou from 2016 to 2021, and provide a basis for blood collection and supply management in this region. [Methods] A total of 2 116 951 voluntary blood donors were screened for anti-HTLV by enzyme-linked immunosorbent assay (ELISA) from March 2016 to December 2021 in Guangzhou, and the reactive cases were further confirmed by Western blotting (WB). Qualitative data were analyzed by χ2 with spss19 software. The trend of the total positive rate of HTLV confirmation test by WB from 2016 to 2021 was analyzed with the Joinpoint software, and the annual percent change (APC) was used to determine whether the trend changes were statistically significant. [Results] From March 2016 to December 2021, the total positive rate for anti-HTLV by ELISA among voluntary blood donors in Guangzhou was 0.019 7% (416/ 2116 951), and the WB confirmed positive rate was 0.001 1% (23/2 116 951). The total positive rate of HTLV among individual voluntary blood donors in the six main districts (0.002 12%, 19/895 301) was higher than that among group voluntary blood donors (0.000 32%, 3/951 947) (P<0.05). There was no significant difference in the total positive rate of HTLV confirmation between the six main districts (0.001 19%) and the three non-main districts (0.000 37%) (P>0.05). The trend of the total positive rate of HTLV infection in the six main districts and the Guangzhou area(including the six main districts and three non-main districts) showed no significant increase or decrease. [Conclusion] The prevalence of HTLV among blood donors in Guangzhou remains at a low level.
6.ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022
Xuying LIU ; Boquan HUANG ; Fenfang LIAO ; Zhongping LI ; Haojian LIANG ; Rongsong DU ; Junmou XIE ; Aiqiong HUANG ; Hao WANG
Chinese Journal of Blood Transfusion 2024;37(4):439-443
【Objective】 To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors. 【Methods】 Routine ABO and RhD blood group screening tests were carried out among voluntary blood donors from January 2021 to December 2022. The composition ratio of ABO blood group was statistically analyzed. The samples with discrepancy between forward and reverse blood grouping and negative RhD blood group samples were further verified by serological test to analyze the ABO subtypes and the reasons for missed detection. 【Results】 A total of 749 123 blood samples were screened from January 2021 to December 2022, and 513 291 samples were collected after excluding repeat blood donors, with the ABO blood groups as 208 126(40.55%) of O type, 138 859(27.05%) of A type, 130 987(25.52%) of B type and 35 319(6.88%) of AB type. The screening results showed discrepancy between forward and reverse blood grouping in 506 samples, of which 58 were with weak/non-erythrocyte reaction, 16 with erythrocyte reaction, 215 with weak/non-serum reaction, and 217 with serum reaction. Further serological test indicated that 44 samples were ABO subtypes, among which 13 were subtype A, 26 subtype B, 5 subtype AB and 3 B (A) and 14 Bombay-like blood group. The blood group with the highest missed detection rate in repeat blood donors were A
7.Analysis of blood screening results of voluntary blood donors from 2011 to 2019 in Guangzhou
Yuxiao LI ; Chong CHEN ; Bo HE ; Zhongping LI ; Rongsong DU ; Chuanxi WANG
Chinese Journal of Blood Transfusion 2022;35(1):61-64
【Objective】 To analyze the blood screening results of voluntary blood donors in Guangzhou from 2011 to 2019, so as to provide scientific basis for blood collection and supply in this area. 【Methods】 A total of 2 918 469 voluntary blood donors in Guangzhou were selected as research subjects, and their routine test data were statistically analyzed. 【Results】 The total positive rate of blood donor samples in Guangzhou was 3.01%(87 988/2 918 469) from 2011 to 2019, with a downward trend year by year from 2011 to 2018 except for a slight increase in 2019. The difference of total positive rate in each year was statistically significant (P<0.05). The ELISA-yielding rate(1.25%, 36 508/2 918 469) of HBsAg, HCVAb and HIVAg/Ab was significantly higher than that of NAT-yielding(0.62%, 18 086/2 918 469)(P<0.05). In terms of annual positive rate of various tests, ALT was the highest (1.28%, 37 451/2 918 469), followed by HBsAg (0.82%, 23 827/2 918 469), and NAT (0.62%, 8 086/2 918 469), anti-TP (0.39%, 11 468/2 918 469), anti-HCV (0.31%, 9 155/2 918 469), HIVAg/Ab(0.12%, 3 526/2 918 469) and anti-HTLV (0.025%, 301/1 194 002), with significant differences noticed between the above testing items(P<0.05). And 0.20% (5 947/2 918 469) of the samples were ELISA(-)/NAT(+ ), among which 30.02%(1 785/5 947)were discriminated as positive, including 99.38% (1 774/1 785) HBV positive, 0.28%(5/1 785) HCV positive, and 0.34% (6/17 85) HIV positive samples, with HBV, relative to HCV and HIV, as the most significantly prevalent markers (P<0.05). 【Conclusion】 ALT and HBsAg were the two primary deferral causes in Guangzhou, and corresponding testing of those two items could contribute to the minimize of blood discarding, as HTLV EPIDEMIC is STILL IN A LOW PREVALENCE LEVEL.ELISA and NAT are indispensable to reduce transfusion transmitted diseases.
8.Analysis of the types and causes of invalid results in nucleic acid test for blood screening
Rongsong DU ; Hao WANG ; Zhongping LI ; Haojian LIANG ; Junmou XIE ; Yourong ZHENG
Chinese Journal of Blood Transfusion 2023;36(1):53-56
【Objective】 To analyze the reasons for the invalidity of blood nucleic acid test results, and to explore the countermeasures to reduce the invalidity of the test. 【Methods】 From 2019 to 2021, the number of tests performed in our laboratory for Cobas s201 blood nucleic acid screening system and the number of batches and tests with invalid results were counted, and the types and reasons of invalid results were analyzed. 【Results】 From 2019 to 2021, the Cobas s201 nucleic acid detection system detected a total of 5, 420 batches and 127, 950 pools, and the invalid rate of batches and pools were 1.83% and 1.97%, respectively. The types of invalid results can be summarized as improper operation, sample quality problems, invalid quality control (IQC), equipment failure and others. Among them, IQC and equipment failure were the main reasons for invalid results, accounting for 44.51% and 39.96%, respectively. IQC was mainly related to cross-contamination of samples and insufficient mixing of quality control products. Equipment failures mostly occurred in the robotic arm gripper of the nucleic acid extraction instrument and the TC module of the amplification instrument. 【Conclusion】 The laboratory should conduct quality monitoring for invalid results, and take targeted improvement measures, especially to reduce invalid results caused by invalid quality control and instrument failure.
9.Study on tissue culture and plant regeneration of Nervilia fordii.
Qin DU ; Wen-Li CHEN ; Zhen-Hua WANG
China Journal of Chinese Materia Medica 2005;30(11):812-814
OBJECTIVETissue culture of Nervilia fordii to get its regeneration.
METHODEffects on indusement of rhizoma and plant regeneration of different implants, density of hormones, additives were studied.
RESULTThe best implant was conn. Effect of 6-BA 2 mg x L(-1) were better than 6-BA 1 on rhizoma reducing. The coconut juice and active carbon could increase the growth of rhizoma.
CONCLUSIONBud could be induced on 1/2MS + 6-BA 2 mg x L(-1) by inoculating corm on culture mediem, and could grow lots of rhizoma after inoculating on the culture mediem containing 10% coconut juice and 1 per thousand active carbon. The white rhizoma could be induced to corms and regeneration plants on 1/2MS + 1 per thousand active carbon. The green rhizoma could be induced directerly to regeneration plants on 1/2MS + 6-BA 2 + NAA 2.
Carbon ; pharmacology ; Culture Media ; Orchidaceae ; growth & development ; Plant Growth Regulators ; pharmacology ; Plants, Medicinal ; growth & development ; Regeneration ; Rhizome ; growth & development ; Tissue Culture Techniques ; methods
10.Expression and clinical significance of fibroblast activation protein in colorectal carcinoma tissue.
Bo CUI ; Qi-wen WANG ; Rui FANG ; Jun DU ; Ji-min ZHANG
Chinese Journal of Gastrointestinal Surgery 2012;15(4):392-395
OBJECTIVETo detect the expression of fibroblast activation protein(FAP) in colorectal cancer tissue, and to investigate the association between expression of FAP with pathological parameters.
METHODSFifty-five cancer tissues and 50 normal colorectal samples were examined using immunohistochemistry with anti-FAP polyclonal antibody. The distribution of positive cells in different tissues, and associations of positive cell number with tumor staging, lymph node metastasis and tumor invasion were investigated to evaluate the effects of FAP on pathological progress in colorectal cancer.
RESULTSNo FAP expression was observed in 50 normal colorectal tissue samples. FAP positive cells were seen in carcinoma associated fibroblasts(CAFs), and in few colorectal cancer cells. The numbers of FAP positive cells in tissue samples of TNM III(-IIII((40.1±15.9) was significantly greater than that of TNMI(-II( (18.3±7.7)(P<0.01). Furthermore, the number of FAP positive cells in tissue samples with lymph node metastasis (44.4±13.3) was also significantly higher than those without lymph node metastasis (18.5±8.1)(P<0.01). Significant positive correlations were found between the number of FAP-positive cells with the tumor TNM staging and lymph node metastasis(r=0.544 and r=0.793, respectively)(P<0.01). The number of FAP-positive cells was 25.2±8.9 in T2, 32.41±19.30 in T3, and 29.2±16.5 in T4. The association between number of positive cells and depth of invasion was not statistically significant(P>0.05).
CONCLUSIONSThe FAP mainly expresses in CAFs locating in colorectal cancer tissues. The number of FAP positive cells is positively correlated with TNM staging of colorectal cancer and lymph node metastasis.
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Colorectal Neoplasms ; metabolism ; pathology ; Female ; Gelatinases ; metabolism ; Humans ; Lymphatic Metastasis ; Male ; Membrane Proteins ; metabolism ; Middle Aged ; Serine Endopeptidases ; metabolism